GSK plc reports

Company location
London
GSK plc has filed 6,805 SEC EDGAR filings since 12 Jan 2001

SEC filing history

Showing 451-475 of 1,000 matching filings.

Per page
25
Current page
19
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
01 May 2025
Reporting date
01 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

NUCALA MATINEE DATA IN COPD PUBLISHED IN NEJM

Filing date
01 May 2025
Reporting date
01 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
01 May 2025
Reporting date
01 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
30 Apr 2025
Reporting date
30 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

1ST QUARTER RESULTS

Filing date
30 Apr 2025
Reporting date
30 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
29 Apr 2025
Reporting date
29 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
28 Apr 2025
Reporting date
28 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
25 Apr 2025
Reporting date
25 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
24 Apr 2025
Reporting date
24 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
23 Apr 2025
Reporting date
23 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
22 Apr 2025
Reporting date
22 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

BLENREP LICENSED BY UK MHRA

Filing date
17 Apr 2025
Reporting date
17 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
17 Apr 2025
Reporting date
17 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

AREXVY NOW ACIP RECOMMENDED FOR 50-59 AT RIS

Filing date
17 Apr 2025
Reporting date
17 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK 5-IN-1 MENINGITIS VACCINE RECOMMENDED IN US

Filing date
17 Apr 2025
Reporting date
17 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
17 Apr 2025
Reporting date
17 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
16 Apr 2025
Reporting date
16 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
15 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
15 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
14 Apr 2025
Reporting date
14 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
14 Apr 2025
Reporting date
14 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
11 Apr 2025
Reporting date
11 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
11 Apr 2025
Reporting date
11 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
10 Apr 2025
Reporting date
10 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TRANSACTION IN OWN SHARES

Filing date
09 Apr 2025
Reporting date
09 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .